Comparison of flow and batch polymerization processes for production of vinyl ether terpolymers for use in the delivery of siRNA
Jason L. Nyrop(Merck & Co., Inc., Rahway, NJ, USA (United States)), Erin N. Guidry(Merck & Co., Inc., Rahway, NJ, USA (United States)), B W. Thuronyi(Williams College), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Rubina Giarre Parmar(United States Military Academy), Ian W. Davies(Princeton University), Bonnie J. Howell(Johns Hopkins University), Arash Soheili(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michel Journet(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jacob H. Waldman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jonathan Williams(University of Liverpool), Bing Mao(Merck & Co., Inc., Rahway, NJ, USA (United States)), Fanyu Meng(United States Military Academy), Lisa DiMichele(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xiujuan Jia(Merck & Co., Inc., Rahway, NJ, USA (United States)), Steven L. Colletti(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rong Xiang(Zhejiang University)
Cited by 3
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409
A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines.
|PubMed|1995|385
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
|Nature Medicine|2021|367